These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8744283)

  • 1. Enzyme-linked immunosorbent assay of neocarzinostatin chromophore (NCS-chr) by use of a monoclonal antibody against NCS-chr analog.
    Mizugaki M; Itoh K; Nakamura H; Ishida N
    J Immunoassay; 1996 May; 17(2):133-44. PubMed ID: 8744283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An antitumor polypeptide antibiotic neocarzinostatin: the mode of apo-protein--chromophore interaction.
    Edo K; Saito K; Akiyama-Murai Y; Mizugaki M; Koide Y; Ishida N
    J Antibiot (Tokyo); 1988 Apr; 41(4):554-62. PubMed ID: 2967272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzyme immunoassay with high sensitivity and accuracy for specific antibody to neocarzinostatin.
    Kitagawa T; Tanimori H; Yoshida K
    J Immunol Methods; 1984 Aug; 72(1):297-303. PubMed ID: 6235292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unstability of neocarzinostatin-chromophore.
    Edo K; Sato H; Saito K; Akiyama Y; Kato M; Mizugaki M; Koide Y; Ishida N
    J Antibiot (Tokyo); 1986 Apr; 39(4):535-40. PubMed ID: 2423490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, production, and characterization of recombinant neocarzinostatin apoprotein in Escherichia coli.
    Nozaki S; Tomioka Y; Hishinuma T; Inoue M; Nagumo Y; Tsuruta LR; Hayashi K; Matsumoto T; Kato Y; Ishiwata S; Itoh K; Suzuki T; Hirama M; Mizugaki M
    J Biochem; 2002 May; 131(5):729-38. PubMed ID: 11983081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induced formation of a DNA bulge structure by a molecular wedge ligand-postactivated neocarzinostatin chromophore.
    Gao X; Stassinopoulos A; Ji J; Kwon Y; Bare S; Goldberg IH
    Biochemistry; 2002 Apr; 41(16):5131-43. PubMed ID: 11955061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding and cleavage characteristics of the complexes formed between the neocarzinostatin chromophore and single site containing oligonucleotides.
    Stassinopoulos A; Goldberg IH
    Bioorg Med Chem; 1995 Jun; 3(6):713-21. PubMed ID: 7582949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biochemical mechanisms of NCS-chromophore-induced DNA cleavage and inhibition of protein kinase activity].
    Ohtsuki K; Tanoue S; Karino A
    Gan To Kagaku Ryoho; 1997 Feb; 24(4):443-53. PubMed ID: 9063482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neocarzinostatin: selective tryptophan oxidation and neocarzinostatin-chromophore binding to apo-neocarzinostatin.
    Edo K; Saito K; Matsuda Y; Akiyama-Murai Y; Mizugaki M; Koide Y; Ishida N
    Chem Pharm Bull (Tokyo); 1991 Jan; 39(1):170-6. PubMed ID: 1828722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA cleavage characteristics of non-protein enediyne antibiotic N1999A2.
    Miyagawa N; Sasaki D; Matsuoka M; Imanishi M; Ando T; Sugiura Y
    Biochem Biophys Res Commun; 2003 Jun; 306(1):87-92. PubMed ID: 12788070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New complex of post-activated neocarzinostatin chromophore with DNA: bulge DNA binding from the minor groove.
    Kwon Y; Xi Z; Kappen LS; Goldberg IH; Gao X
    Biochemistry; 2003 Feb; 42(5):1186-98. PubMed ID: 12564921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioimmunoassay of neocarzinostatin, an antitumor protein.
    Samy TS; Raso V
    Cancer Res; 1976 Dec; 36(12):4378-81. PubMed ID: 63321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical synthesis and cytotoxicity of dihydroxylated cyclopentenone analogues of neocarzinostatin chromophore.
    Urbaniak MD; Frost LM; Bingham JP; Kelland LR; Hartley JA; Woolfson DN; Caddick S
    Bioorg Med Chem Lett; 2003 Jun; 13(12):2025-7. PubMed ID: 12781188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neocarzinostatin as a probe for DNA protection activity--molecular interaction with caffeine.
    Chin DH; Li HH; Kuo HM; Chao PD; Liu CW
    Mol Carcinog; 2012 Apr; 51(4):327-38. PubMed ID: 21538576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tumor growth inhibitory effects of SMANCS, a poly (styrene-maleic acid) conjugated derivative of neocarzinostatin, on various tissue culture cells].
    Suzuki F; Okuno Y; Maeda Y; Maeda H
    Gan To Kagaku Ryoho; 1987 Dec; 14(12):3305-12. PubMed ID: 2961306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neocarzinostatin chromophore. Assignment of spectral properties and structural requirements for binding to DNA.
    Napier MA; Goldberg IH
    Mol Pharmacol; 1983 Mar; 23(2):500-10. PubMed ID: 6220205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enediyne-mediated cleavage of RNA.
    Battigello JM; Cui M; Roshong S; Carter BJ
    Bioorg Med Chem; 1995 Jun; 3(6):839-49. PubMed ID: 7582960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of secondary structure of neocarzinostatin apoprotein.
    Saito K; Sato Y; Edo K; Akiyama-Murai Y; Koide Y; Ishida N; Mizugaki M
    Chem Pharm Bull (Tokyo); 1989 Nov; 37(11):3078-82. PubMed ID: 2534360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis for the sequence-specific DNA strand cleavage by the enediyne neocarzinostatin chromophore. Structure of the post-activated chromophore-DNA complex.
    Gao X; Stassinopoulos A; Rice JS; Goldberg IH
    Biochemistry; 1995 Jan; 34(1):40-9. PubMed ID: 7819222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of activation of the antitumor antibiotic neocarzinostatin by mercaptan and sodium borohydride.
    Hensens OD; Goldberg IH
    J Antibiot (Tokyo); 1989 May; 42(5):761-8. PubMed ID: 2524463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.